Related Experiment Videos
Infants of diabetic mothers. Fetal and neonatal pathophysiology
Insights
Infants of diabetic mothers (IDMs) face immediate neonatal complications due to abnormal fetal development from high maternal glucose. These infants often experience hypoglycemia, respiratory issues, and other metabolic disturbances after birth.
Area of Science:
- Neonatal Medicine
- Endocrinology
- Developmental Biology
Background:
- Infants of diabetic mothers (IDMs) exhibit unique physiological adaptations in utero due to increased maternal glucose transfer.
- These adaptations include fetal hyperglycemia, hyperinsulinemia, and altered metabolic processes impacting organ development.
Purpose of the Study:
- To outline the spectrum of immediate neonatal clinical problems in infants of diabetic mothers (IDMs).
- To elucidate the underlying abnormal fetal developmental physiology contributing to these neonatal complications.
Main Methods:
- This abstract is a review of known physiological responses and clinical outcomes.
- It synthesizes information on fetal and neonatal adaptations to maternal diabetes.
Main Results:
- Fetal hyperglycemia and hyperinsulinemia lead to macrosomia, altered fat and glycogen storage, and potential cardiac and lung developmental changes.
- At birth, IDMs are prone to hypoglycemia, respiratory distress (IRDS, PPHN, CHF), hyperbilirubinemia, hypocalcemia, hypomagnesemia, and thrombosis.
Conclusions:
- The immediate neonatal period for IDMs is characterized by significant clinical challenges stemming from in utero metabolic and developmental alterations.
- Understanding these physiological changes is crucial for managing the complex health needs of IDMs.
Abstract:
Most of the clinical problems experienced by the IDM in the immediate neonatal period are manifestations of abnormal fetal developmental physiology that occur in response to an increased flux of glucose from mother to fetus. The principal fetal responses are hyperglycemia, hyperinsulinemia, increased metabolic rate, and hypoxemia. Those fetal responses very likely lead to a redistribution of cardiac output, increased release of norepinephrine, and blunted release of glucagon. More fat is stored in adipocytes; more glycogen is stored in the liver; the heart may develop asymmetric septal hypertrophy; and lung metabolism is altered to delay the appearance of mature surfactant. At birth, the macrosomic IDM develops hypoglycemia that has a multifactorial basis (hyperinsulinemia, hypoglucagonemia, and probably diminished gluconeogenic and cortisol production rates). The IDM may experience respiratory symptoms from one of three causes: IRDS, persistent pulmonary hypertension, or congestive heart failure. Hyperbilirubinemia may occur because of increased rate of hemolysis; hypocalcemia and hypomagnesemia are likely within the first 3 days in association with a sluggish PTH response; and abnormal levels of inhibitors of fibrinolysis and platelet prostaglandin E-like substances may stimulate abnormal thrombosis.